Compare CFG & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFG | DXCM |
|---|---|---|
| Founded | 1828 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 25.9B |
| IPO Year | N/A | 2005 |
| Metric | CFG | DXCM |
|---|---|---|
| Price | $59.01 | $70.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 21 |
| Target Price | $67.85 | ★ $85.00 |
| AVG Volume (30 Days) | ★ 4.8M | 4.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | N/A | ★ 2.09 |
| Revenue | N/A | N/A |
| Revenue This Year | $20.13 | $14.46 |
| Revenue Next Year | $8.13 | $12.39 |
| P/E Ratio | ★ $16.85 | $34.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.60 | $54.11 |
| 52 Week High | $68.79 | $89.07 |
| Indicator | CFG | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 45.79 |
| Support Level | $58.58 | $63.69 |
| Resistance Level | $59.70 | $74.08 |
| Average True Range (ATR) | 1.78 | 2.37 |
| MACD | -0.78 | -0.10 |
| Stochastic Oscillator | 2.99 | 66.98 |
Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through the bank, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The company's reportable segments are; Commercial Banking, Consumer Banking, Non-Core, and Others. A majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management and investment services.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.